Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality of Treatment Selection for Medicare Beneficiaries With Cancer.
Mitchell AP, Persaud S, Mishra Meza A, Fuchs HE, De P, Tabatabai S, Chakraborty N, Dey P, Trivedi NU, Mailankody S, Blinder V, Green A, Epstein AS, Daly B, Roeker L, Bach PB, Gönen M. Mitchell AP, et al. Among authors: tabatabai s. J Clin Oncol. 2024 Oct 11:JCO2400459. doi: 10.1200/JCO.24.00459. Online ahead of print. J Clin Oncol. 2024. PMID: 39393041
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system.
Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED. Bhimani J, et al. Among authors: tabatabai s. Breast Cancer Res Treat. 2024 Nov;208(2):405-414. doi: 10.1007/s10549-024-07433-4. Epub 2024 Aug 16. Breast Cancer Res Treat. 2024. PMID: 39150586
Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer.
Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski-Doud RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED. Bhimani J, et al. Among authors: tabatabai s. Cancer Epidemiol Biomarkers Prev. 2024 Oct 2;33(10):1286-1297. doi: 10.1158/1055-9965.EPI-24-0360. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 39051907
130 results